You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (72)

Journals (0)

1-10 of 72 results for EGFR-TKI resistance

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study

Open access

Research article

First published 2025

Treatment options for EGFR mutation-positive NSCLC patients with leptomeningeal metastases after third-generation TKI resistance: a retrospective real-world study

Wenhua Yun, Ailing Liu, Junxu Wen [...]

Therapeutic Advances in Medical Oncology

Select article: BLU-945,a potent and selective next-generation EGFR TKI,has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

Open access

Research article

First published 2024

BLU-945,a potent and selective next-generation EGFR TKI,has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer

Sun Min Lim, Stefanie S. Schalm, Eun Ji Lee [...]

Therapeutic Advances in Medical Oncology

Select article: Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Retricted access

Research article

First published 2014-01

Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Paola Bordi, Marcello Tiseo, Beatrice Bortesi [...]

Tumori Journal

Select article: Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Select article: Primary TKI Resistance in Advanced Non-small Cell Lung Cancer with EGFR Mutation: An Open Question

Retricted access

Case report

First published 2015-7

Primary TKI Resistance in Advanced Non-small Cell Lung Cancer with EGFR Mutation: An Open Question

Jacopo Giuliani, Salvatore Martelli, Andrea Remo [...]

Tumori Journal

Select article: Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis

Open access

Research article

First published 2025

Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis

Yueying Chen, Yanjun Du, Juan Ni [...]

Therapeutic Advances in Medical Oncology

Select article: Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study

Open access

Research article

First published 2025

Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study

Jingyi Wang, Bolin Chen, Xingxiang Pu [...]

Therapeutic Advances in Medical Oncology

Select article: Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Select article: The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients

Free access

Research article

First published 2022-2

The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients

Hao Ding, Yuxing Chen, Yuanyang Zhao [...]

Cancer Biomarkers

Select article: Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Free access

Review article

First published 2016-5

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Ourania Romanidou, Lorenza Landi, Federico Cappuzzo [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access